Literature DB >> 26663193

microRNAs and Hepatitis B.

Yutaka Naito1, Yasuhito Tanaka2, Takahiro Ochiya3.   

Abstract

The hepatitis B virus (HBV) infection is the leading cause of persistent liver diseases, cirrhosis, and hepatocellular carcinoma (HCC). However, the precise mechanism underlying the development of HBV-related diseases is not fully understood. In addition, the therapeutic strategies for the diseases are less than optimum. microRNAs (miRNAs) are small noncoding RNAs that have been described as a "fine-tuner" in various cellular events. The dysregulation of miRNAs play a role in the development of the cancer as well as viral interference. Recent articles have demonstrated that several miRNAs are deregulated by HBV infection and contribute to viral replication and pathogenesis. Thus, it suggests that the precise mechanism between miRNA and HBV biology will be leading to the development of the novel diagnosis and therapy. This chapter aims to provide the basic principals of miRNAs in development of the HBV-related diseases. We also discuss about the possibility of miRNAs on the clinical application for diagnosis and therapy of HBV-related diseases.

Entities:  

Keywords:  Hepatitis B virus; Hepatocellular carcinoma; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26663193     DOI: 10.1007/978-3-319-22671-2_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma.

Authors:  Jing Shen; Qiao Wang; Irina Gurvich; Helen Remotti; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-11-18

2.  Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients.

Authors:  Xianliang Hou; Yan Liang; Jianing Chen; Yingfeng Wei; Ping Zeng; Lin Wang; Chong Lu; Hongyan Diao
Journal:  Biomed Res Int       Date:  2017-08-23       Impact factor: 3.411

3.  Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection.

Authors:  Yiying Wang; Peifu Zhu; Jing Qiu; Jie Wang; Huijuan Zhu; Yinwei Zhu; Lige Zhang; Jie Zhu; Xingxiang Liu; Chen Dong
Journal:  Clin Epigenetics       Date:  2017-09-16       Impact factor: 6.551

4.  Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.

Authors:  Qingqing Fang; Wei Chen; Yourong Jian; Yu Li; Wei Lian; Hongyu Wan; Shiyao Chen; Feng Li; Ying Chen
Journal:  J Healthc Eng       Date:  2022-02-24       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.